Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Biochem Biophys Res Commun ; 486(3): 759-766, 2017 05 06.
Article in English | MEDLINE | ID: mdl-28342869

ABSTRACT

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system, and its pathogenesis remains largely unclear. Much attention has been paid to the role of microRNAs (miRs) in regulation of autoimmune disease. Here, we found, for the first time, that miR-448 expression was significantly increased in periphery blood mononuclear cells (PBMC) and cerebrospinal fluid (CSF) of patients with MS, and its expression positively correlated with the disease severity. We further demonstrated that CD4+ T cells, especially the Th17 lineage, were the major source of miR-448 expression. Using gain- and loss-of-function approaches, we further verified that miR-448 could enhance Th17 differentiation, characterized by up-regulated expression levels of IL-17A and RORγt. Interleukin (IL)-1ß as a potent driver of pathogenic Th17 cells was able to strongly induce miR-448 expression in CD4+ T cells through activating NF-κB pathway. Additionally, we identified that miR-448 directly targeted protein tyrosine phosphatase non-receptor type 2 (PTPN2), which has been known as an anti-inflammatory player with capacity to suppress Th17 differentiation. We also observed markedly decreased expression of PTPN2 in PBMC and CSF of MS patients. Our results suggest that miR-448 might promote Th17 differentiation in MS and thus aggravate the disease through inhibiting PTPN2.


Subject(s)
Interleukin-17/genetics , MicroRNAs/genetics , Multiple Sclerosis/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 2/genetics , Th17 Cells/pathology , B-Lymphocytes/immunology , B-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Case-Control Studies , Cell Differentiation , Gene Expression Regulation , Genes, Reporter , Humans , Interleukin-17/immunology , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Luciferases/genetics , Luciferases/metabolism , MicroRNAs/immunology , Multiple Sclerosis/diagnosis , Multiple Sclerosis/immunology , Multiple Sclerosis/pathology , NF-kappa B/genetics , NF-kappa B/immunology , Neutrophils/immunology , Neutrophils/pathology , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/immunology , Primary Cell Culture , Protein Tyrosine Phosphatase, Non-Receptor Type 2/immunology , Remission Induction , Severity of Illness Index , Signal Transduction , Th17 Cells/immunology
2.
Acta Pharmacol Sin ; 35(4): 504-12, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24608675

ABSTRACT

AIM: Free fatty acid-induced lipotoxicity plays a crucial role in the progression of nonalcoholic fatty liver disease (NAFLD). In the present study we investigated the effects of a high-fat diet and free fatty acids on the autophagic process in hepatocytes in vivo and in vitro and the underlying mechanisms. METHODS: LC3-II expression, a hallmark of autophagic flux, was detected in liver specimens from patients with non-alcoholic steatohepatitis (NASH) as well as in the livers of C57BL/6 mice fed a high-fat diet (HFD) up to 16 weeks. LC3-II expression was also analyzed in human SMMC-7721 and HepG2 hepatoma cells exposed to palmitic acid (PA), a saturated fatty acid. PA-induced apoptosis was detected by Annexin V staining and specific cleavage of PARP in the presence and absence of different agents. RESULTS: LC3-II expression was markedly increased in human NASH and in liver tissues of HFD-fed mice. Treatment of SMMC-7721 cells with PA increased LC3-II expression in time- and dose-dependent manners, whereas the unsaturated fatty acid oleic acid had no effect. Inhibition of autophagy with 3MA sensitized SMMC-7721 cells to PA-induced apoptosis, whereas activation of autophagy by rapamycin attenuated PA-induced PARP cleavage. The autophagy-associated proteins Beclin1 and Atg5 were essential for PA-induced autophagy in SMMC-7721 cells. Moreover, pretreatment with SP600125, an inhibitor of JNK, effectively abrogated PA-mediated autophagy and apoptosis. Specific knockdown of JNK2, but not JNK1, in SMMC-7721 cells significantly suppressed PA-induced autophagy and enhanced its pro-apoptotic activity; whereas specific knockdown of JNK1 had the converse effect. Similar results were obtained when HepG2 cells were tested. CONCLUSION: JNK1 promotes PA-induced lipoapoptosis, whereas JNK2 activates pro-survival autophagy and inhibits PA lipotoxicity. Our results suggest that modulation of autophagy may have therapeutic benefits in the treatment of lipid-related metabolic diseases.


Subject(s)
Autophagy/drug effects , Hepatocytes/drug effects , Mitogen-Activated Protein Kinase 9/metabolism , Non-alcoholic Fatty Liver Disease/enzymology , Palmitic Acid/toxicity , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Autophagy-Related Protein 5 , Beclin-1 , Diet, High-Fat , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme Activation , Hep G2 Cells , Hepatocytes/enzymology , Hepatocytes/pathology , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice, Inbred C57BL , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Mitogen-Activated Protein Kinase 8/genetics , Mitogen-Activated Protein Kinase 8/metabolism , Mitogen-Activated Protein Kinase 9/antagonists & inhibitors , Mitogen-Activated Protein Kinase 9/genetics , Non-alcoholic Fatty Liver Disease/etiology , Non-alcoholic Fatty Liver Disease/genetics , Non-alcoholic Fatty Liver Disease/pathology , Protein Kinase Inhibitors/pharmacology , RNA Interference , Signal Transduction/drug effects , Time Factors , Transfection
3.
Hepatology ; 54(5): 1620-30, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21809356

ABSTRACT

UNLABELLED: One of the challenges surrounding nonalcoholic fatty liver disease (NAFLD) is to discover the mechanisms that underlie the initiation of it. The aim of the present study was to elucidate the effects of Toll-like receptor 4 (TLR4) signaling in liver parenchymal cells during the early stage of NAFLD. Male TLR4-wildtype, TLR4-knockout, TLR2-knockout, MyD88-knockout, and TRIF-knockout mice were fed a normal diet or high-fat diet (HFD). Liver steatosis, alanine aminotransferase levels, nuclear translocation of nuclear factor kappa B (NF-κB) (p65), macrophage accumulation, and neutrophil infiltration were assessed. Using Kupffer cell depletion or bone marrow transplantation, we examined the potential role of Kupffer cells and myeloid infiltrating cells during the initiation of NAFLD. Immunohistochemistry and western blotting were implemented to determine the release of high-mobility group box1 (HMGB1). The neutral-antibody against HMGB1 was used to block the activity of free HMGB1. Here we report that the activation of TLR4 signaling in hepatocytes, accompanied with the relocation of P65 in nucleus, was proven to play an important role during the initiation of NAFLD. Importantly, HMGB1 releasing from hepatocytes in response to free fatty acid (FFA) infusion was first reported as the key molecule for the TLR4/MyD88 activation and cytokines expression in vitro and in vivo. Treatment with neutralizing antibody to HMGB1 protects against FFA-induced tumor necrosis factor alpha and interleukin-6 production. CONCLUSION: Our study supports the notion that TLR4/MyD88 signaling in liver parenchymal cells plays a pivotal role during the early progression of HFD-induced NAFLD, in which free HMGB1 served as a positive component mediating TLR4 activation.


Subject(s)
Fatty Liver/metabolism , HMGB1 Protein/metabolism , Hepatocytes/metabolism , Signal Transduction/physiology , Toll-Like Receptor 4/metabolism , Animals , Cytokines/metabolism , Fatty Liver/pathology , Fatty Liver/physiopathology , HMGB1 Protein/genetics , Hepatocytes/pathology , Kupffer Cells/metabolism , Kupffer Cells/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Cells/metabolism , Myeloid Cells/pathology , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/metabolism , NF-kappa B/metabolism , Non-alcoholic Fatty Liver Disease , Toll-Like Receptor 4/genetics
4.
World J Gastroenterol ; 17(10): 1292-303, 2011 Mar 14.
Article in English | MEDLINE | ID: mdl-21455328

ABSTRACT

AIM: To study the prognostic factors for intrahepatic cholangiocarcinoma (ICC) and evaluate the impact of chronic hepatitis B virus (HBV) infection on survival rate of ICC patients. METHODS: A total of 155 ICC patients who underwent macroscopic curative resections (R0 and R1) were enrolled in this retrospective study and divided into group A with HBV infection and group B without HBV infection according to their chronic HBV infection, represented by positive hepatitis B surface antigen (HBsAg) in serum or in liver tissue. Clinicopathological characteristics and survival rate of the patients were evaluated. RESULTS: All patients underwent anatomical resection. Their 1- and 3-year survival rates were 60.6% and 32.1%, respectively. Multivariate analyses revealed that HBV infection, hepatolithiasis, microscopic satellite lesion, and lymphatic metastasis were the independent prognostic factors for the survival rate of ICC patients. The median disease-free survival time of the patients was 5.0 mo. The number of tumors, microscopic satellite lesion, and vascular invasion were the independent prognostic factors for the disease-free survival rate of the patients. The prognostic factors affecting the survival rate of ICC patients with HBV infection and those without HBV infection were not completely consistent. Alkaline phosphatase > 119 U/L, microscopic satellite lesion, vascular invasion, and lymphatic metastasis were the independent factors for the patients with HBV infection, while r-glutamyltransferase > 64 U/L, microscopic satellite lesion, and poor tumor differentiation were the independent factors for the patients without HBV infection. CONCLUSION: HBV infection is a valuable clinical factor for predicting tumor invasiveness and clinical outcome of ICC patients. ICC patients with HBV infection should be distinguished from those without HBV infection because they have different clinicopathological characteristics, prognostic factors and outcomes after surgical resection.


Subject(s)
Hepatitis B Surface Antigens/metabolism , Hepatitis B/diagnosis , Hepatitis B/virology , Adult , Aged , Bile Duct Neoplasms/diagnosis , Bile Duct Neoplasms/surgery , Bile Duct Neoplasms/virology , Bile Ducts, Intrahepatic , Cholangiocarcinoma/diagnosis , Cholangiocarcinoma/surgery , Cholangiocarcinoma/virology , Female , Hepatitis B virus/metabolism , Humans , Liver/virology , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Liver Neoplasms/virology , Male , Middle Aged , Multivariate Analysis , Neoplasm Invasiveness , Prognosis , Retrospective Studies , Treatment Outcome
5.
Front Med China ; 4(4): 399-411, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21107751

ABSTRACT

ß-catenin is a key molecule involved in both cell-cell adhesion and Wnt signaling pathway. In our study, we found that, in the development of hepatocellular carcinoma (HCC), ß-catenin was correlated with hepatitis B virus (HBV) X gene encoded protein, which is essential for HBV infectivity and is a potential cofactor in viral carcinogenesis. The expression levels of wild-type ß-catenin and E-cadherin were decreased in HepG2 cells expressing hepatitis B virus X protein (HBx), accompanied by destabilization of adherens junction. Reverse transcriptase PCR (RT-PCR), Northern and Western blot showed that reduction of wild-type ß-catenin expression involved degradation of the protein. However, RNA interference (RNAi) and luciferase assay indicated that HBx enhanced ß-catenin mediated signaling in HepG2 cells. In addition, immunohistochemical and Western blot analysis of ß-catenin revealed that a decrease in the ß-catenin protein level was found in 58.3% of HBV-related HCCs versus 19.2% of non-HBV-related tumors. Our data suggest that the expression of HBx contributed to the development of HCC, in part, by repressing the wild-type ß-catenin expression and enforcing ß-catenin-dependent signaling pathway, thus inducing cellular changes leading to acquisition of metastatic and/or proliferation properties.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/virology , Hepatitis B, Chronic/physiopathology , Hepatitis B, Chronic/virology , Liver Neoplasms/metabolism , Liver Neoplasms/virology , Trans-Activators/metabolism , beta Catenin/biosynthesis , Adherens Junctions/pathology , Blotting, Northern , Blotting, Western , Cadherins/biosynthesis , Down-Regulation , Fluorescent Antibody Technique , Gene Expression , Gene Expression Regulation, Viral , Hep G2 Cells , Hepatitis B virus/genetics , Humans , Retrospective Studies , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Trans-Activators/genetics , Transcriptional Activation , Viral Regulatory and Accessory Proteins
6.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 41(4): 669-73, 2010 Jul.
Article in Chinese | MEDLINE | ID: mdl-20848793

ABSTRACT

OBJECTIVE: To investigate the association between IL-1beta and DVWA gene and Kashin-Beck disease (KBD). METHODS: Peripheral genomic DNA were extracted from 105 patients with KBD and 98 healthy controls. PCR-RFLP were performed to detect SNP loci of IL-1beta gene and DVWA gene. RESULTS: The patients with KBD had significantly higher frequency of rs16944 (IL-1beta) locus (chi2 = 24.28, P < 0.001) and single allele frequency of rs16944 (chi2 = 5.683, P = 0.0171) than the healthy controls. There were no significant differences in genotype frequencies,single allele frequencies and haplotypes in rs4685241 and rs1143627 between the patients with KBD and the healthy controls. CONCLUSION: rs16944 (IL-1beta) is associated with KBD.


Subject(s)
Collagen Type VI/genetics , Interleukin-1beta/genetics , Kashin-Beck Disease/genetics , Polymorphism, Single Nucleotide , Adult , Case-Control Studies , Female , Gene Frequency , Humans , Male , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Pseudogenes
7.
Zhonghua Gan Zang Bing Za Zhi ; 17(12): 935-9, 2009 Dec.
Article in Chinese | MEDLINE | ID: mdl-20038337

ABSTRACT

OBJECTIVE: To explore the potential risk factors of intrahepatic cholangiocarcinoma (ICC) in China. METHOD: A case-control study including 317 patients with pathologically confirmed ICC and 634 healthy individuals was conducted. The cases and controls were matched in age, sex and inhabitancy. Data were statistically analyzed by Chi-square test and conditional logistic regression. RESULTS: Univariate analysis showed significant difference in HBsAg seropositivity, liver cirrhosis, hepatolithiasis, choledocholithiasis and schistosomiasis between ICC patients and healthy controls (P < 0.05). Multivariate analysis confirmed that HBsAg seropositivity, liver cirrhosis, hepatolithiasis and hepatic schistosomiasis were associated with ICC, and their adjusted odds ratio (95% confidence interval) were 10.265 (6.676-15.783), 13.101 (5.265-32.604), 18.242 (3.580-92.958), 18.435 (1.930-176.082), 15.102 (4.607-49.499) and 11.820 (3.522-39.668), respectively. The incidence of hepatic cyst, cholecystolithiasis, hepatic hemangioma, fatty liver, diabetes mellitus, smoking and drinking were not significantly different between ICC patients and controls. CONCLUSIONS: The HBV infection, liver cirrhosis, hepatolithiasis and hepatic schistosomiasis may be the risk factors for ICC in China.


Subject(s)
Bile Duct Neoplasms/etiology , Bile Ducts, Intrahepatic , Cholangiocarcinoma/etiology , Cholelithiasis/complications , Hepatitis B/complications , Adult , Aged , Bile Duct Neoplasms/epidemiology , Case-Control Studies , Cholangiocarcinoma/epidemiology , Cholelithiasis/epidemiology , Female , Hepatitis B/epidemiology , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/epidemiology , Liver Diseases/complications , Liver Diseases/epidemiology , Logistic Models , Male , Middle Aged , Odds Ratio , Risk Factors
8.
Zhonghua Nan Ke Xue ; 14(2): 106-9, 2008 Feb.
Article in Chinese | MEDLINE | ID: mdl-18390172

ABSTRACT

OBJECTIVE: To develop a new method for the detection of male human papillomavirus (HPV) genotypes and to investigate its clinical application value. METHODS: With computer assistance and based on the classical common primers MY09/11, modified PGMY09/11 with 23 HPV subtypes for PCR and Genbank data on HPV, we designed probes for the simultaneous detection of 18 high-risk subtypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 83 and MM4) and 5 low-risk subtypes (HPV-6, 11, 42, 43 and 44) and fixed them to the special membrane to make a DNA chip. A total of 112 male urethral samples were collected with swabs and studied for the clinical value. Meanwhile the single subtypes of HPV positive were sequenced and the standard samples detected for their sensitivity. RESULTS: Of the total number, 25 samples were found to be HPV positive, 13 single HPV infection and 12 multiple infection. Nine HPV gene subtypes were noted in the samples: 6, 11, 16, 18, 33, 35, 43, 56 and 73, with sensitivity up to 10 copies of HPV DNA. CONCLUSION: Human papillomavirus genotyping by the membrane DNA chip is applicable to the diagnosis of male HPV infection as well as to the related epidemic and etiological investigation.


Subject(s)
Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , Papillomavirus Infections/virology , Adult , Aged , Base Sequence , DNA Probes, HPV/genetics , DNA, Viral/genetics , DNA, Viral/isolation & purification , Genotype , Humans , In Situ Hybridization , Male , Middle Aged , Molecular Sequence Data , Papillomaviridae/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...